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Background: US population-based estimates of congenital heart disease (CHD) birth prevalence and mortality offer important but insufficient 
information to derive estimates of lifetime prevalence. Our goal was to generate a contemporary estimate of the age and sex distribution of the CHD 
population in the US through a combination of empirical and modeled data from the US and Canada.
Methods: The population-based prevalence of CHD was measured from 1990-2000 in Québec, in subgroups defined by age, sex and CHD severity. 
Using Monte Carlo simulations, we applied demographic differences between the US and Canadian populations to the Québec prevalence estimates 
to arrive at estimates for US prevalence indexed to 2010 census data. Estimated ranges for the prevalence and the total number of individuals with 
CHD alive in the year 2010 incorporate uncertainty around demographic differences and assumptions about changing prevalence since 2000. All 
rates and numbers are reported per 1,000 population or rounded to the nearest 1,000.
Results: Estimated ranges for CHD prevalence and population size in the US in year 2010 are presented in the Table.
Conclusions: Approximately 2 million people were estimated to be alive with CHD in the US in 2010, with a slight predominance of females 
compared to males and adults compared to children. Although further studies are needed to obtain more granular estimates, these findings should 
inform the organization of health services delivery for this growing population in the US.
